We conclude that tumor-derived PGE2 impairs the accumulation and spatial positioning of cDC1 within the TME and that an unknown mechanism induces the accumulation of cDC1 in COX-deficient tumors, which is key for subsequent CD8+ T cell-mediated anti-cancer immunity. The gene discussed is CD8A; the disease is neoplasm.